Your Health, We Care
Lumakras
Krazati
Vitrakvi
Lorbrena
Xospata
Tabrecta
Xpovio
Tibsovo
Mobocertinib
Lynparza
Ninlaro
Venclexta
Scemblix
Filspari
Litfulo
Pemazyre
Gavreto
Retevmo
Idhifa
Cyproterone Acetate
Mekinist
Tafinlar
Doptelet
Cabometyx
Tagrisso
Revolade
Xalkori
Kerendia
Lysodren
Abrocitinib
Adlumiz
Alunbrig
Selumetinib
Piqray
Erdafitinib
Diacomit
Dificid
Iclusig
Lenvima
Tukysa
Sabril
Rozlytrek
Rinvoq
Fotivda
Augtyro
Tepmetko
Belumosudil mesylate tablets
Sotyktu
Ojjaara
Jaypirca
Jyseleca
Jesduvroq
Vizimpro
Vanflyta
Valganciclovir
Zelboraf
Zykadia
Alecensa
Gemtesa
Imbruvica
Gilotrif
Zafatek
Veozah
Stivarga
Xeljanz
Tryvio
Inlyta
Welireg
Truqap
Sutent
Agrylin
Mektovi
Orserdu
Rezdiffra
Lytgobi
Tazverik
Verzenios
Calquence
Volibris
Ayvakit
Olumiant
bictegravir/emtricitabine/tenofovir alafenamide
Tracleer
Dostinex
Cotellic
Sprycel
Iqirvo
Braftovi
Sofosbuvir and Velpatasvir Tablets
Tarceva
Afinitor
Iressa
Zydelig
Truseltiq
Leclaza
Sunlenca
Revlimid
Mulpleta
Opsumit
Camzyos
Nerlynx
OFEV
Zejula
Ocaliva
Bylvay
Vonjo
EsbrietOn November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：662025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：3652024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：602025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：792025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：732025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：932025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：882025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：912025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
